SHA:603168 Revenue

Zhejiang Shapuaisi Pharmaceutical had revenue of 114.54M CNY in the quarter ending September 30, 2025, a decrease of -6.54%. This brings the company's revenue in the last twelve months to 475.19M, down -6.01% year-over-year. In the year 2024, Zhejiang Shapuaisi Pharmaceutical had annual revenue of 483.96M, down -24.96%.

Revenue (ttm)

475.19M

Revenue Growth

-6.01%

P/S Ratio

5.91

Revenue / Employee

357.82K

Employees

1,328

Market Cap

2.81B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	483.96M	-161.01M	-24.96%
Dec 31, 2023	644.97M	95.43M	17.37%
Dec 31, 2022	549.54M	-80.23M	-12.74%
Dec 31, 2021	629.76M	282.96M	81.59%
Dec 31, 2020	346.81M	-169.15M	-32.78%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Anhui Fengyuan Pharmaceutical	4.15B
Hainan Huluwa Pharmaceutical Group	1.06B
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	914.65M
Enwei Pharmaceutical	888.64M
Chengdu huasun technology group Inc. , LTD.	658.28M
Ginwa Enterprise (Group)	550.44M
Shaanxi Kanghui Pharmaceutical	513.23M
Anhui Huangshan Capsule	471.08M

Revenue Rankings